Skip to main content

Pharmacokinetic Model-Driven Remifentanil Administration in the Morbidly Obese

The ‘Critical Weight’ and the ‘Fictitious Height’, a Possible Solution to an Unsolved Problem?

Clinical Pharmacokinetics volume 48, pages 397–398 (2009)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 49.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. La Colla L, Albertin A, La Colla G, et al. Target controlled infusion of remifentanil: beware when using it in morbidly obese patients. First World Congress of Total Intravenous Anesthesia — TCI; 2007 Sep 27–29; Venice

    Google Scholar 

  2. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil: I. Model development. Anesthesiology 1997; 86: 10–23

    Article  PubMed  CAS  Google Scholar 

  3. James WPT, Waterlow JC. UK Department of Health and Social Security/Medical Research Council Group on Obesity Research. Research on obesity: a report of the DHSS/MRC Group. London: HMSO [Her Majesty’s Stationery Office], 1976

  4. Green B, Duffull S. Caution when lean body weight is used as a size descriptor for obese subjects. Clin Pharmacol Ther 2002; 72: 743–4

    Article  PubMed  Google Scholar 

  5. Janmahasatian S, Duffull SB, Ash S, et al. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44: 1051–65

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

These data and simulations have been presented in part at the First World Congress of Total Intravenous Anaesthesia — TCI, 27–29 September 2007, Venice, Italy. Support was provided solely from institutional/departmental sources. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Vita-Salute San Raffaele University School of Medicine-IRCCS San Raffaele, Milan, Italy

    L. La Colla

  2. Department of Anesthesiology, IRCCS Multimedica, Sesto S. Giovanni, Milan, Italy

    A. Albertin

  3. Department of Anaesthesiology, University of Modena and Reggio Emilia, Modena, Italy

    G. La Colla

Authors
  1. L. La Colla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Albertin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. La Colla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. La Colla.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

La Colla, L., Albertin, A. & La Colla, G. Pharmacokinetic Model-Driven Remifentanil Administration in the Morbidly Obese. Clin Pharmacokinet 48, 397–398 (2009). https://doi.org/10.2165/00003088-200948060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-200948060-00005

Keywords

  • Obese Patient
  • Pharmacokinetic Parameter
  • Remifentanil
  • Lean Body Mass
  • Pharmacokinetic Model